206 related articles for article (PubMed ID: 7143218)
1. Bioavailability of griseofulvin from tablets in beagle dogs and correlation with dissolution rate and bioavailability in humans.
Aoyagi N; Ogata H; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A; Tamaki N; Kamimura H; Katougi Y; Omi Y
J Pharm Sci; 1982 Oct; 71(10):1169-72. PubMed ID: 7143218
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of griseofulvin from tablets in humans and the correlation with its dissolution rate.
Aoyagi N; Ogata H; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A
J Pharm Sci; 1982 Oct; 71(10):1165-9. PubMed ID: 7143217
[TBL] [Abstract][Full Text] [Related]
3. Effect of food on the bioavailability of griseofulvin from microsize and PEG ultramicrosize (GRIS-PEG) plain tablets.
Aoyagi N; Ogata H; Kaniwa N; Ejima A
J Pharmacobiodyn; 1982 Feb; 5(2):120-4. PubMed ID: 7097474
[TBL] [Abstract][Full Text] [Related]
4. Comparative bioavailability of a microsize and ultramicrosize griseofulvin formulation in man.
Lin C; Lim J; DiGiore C; Gural R; Symchowicz S
J Int Med Res; 1982; 10(4):274-7. PubMed ID: 7117684
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability of microsize and ultramicrosize griseofulvin products in man.
Straughn AB; Meyer MC; Raghow G; Rotenberg K
J Pharmacokinet Biopharm; 1980 Aug; 8(4):347-62. PubMed ID: 7431226
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of different brands of griseofulvin tablets and its correlation to dissolution data.
Khalafalla N; Elgholmy ZA; Khalil SA
Pharmazie; 1980 Aug; 35(8):482-4. PubMed ID: 7433499
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of griseofulvin from plain tablets in Göttingen minipigs and the correlation with bioavailability in humans.
Aoyagi N; Ogata H; Kaniwa N; Ejima A; Yasuda Y; Tanioka Y
J Pharmacobiodyn; 1984 Jan; 7(1):7-14. PubMed ID: 6726615
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of Nalidixic acid from uncoated tablets in humans--Part II: Bioavailability in beagles and its correlation with bioavailability in humans and in vitro dissolution rates.
Ogata H; Aoyagi N; Kaniwa N; Shibazaki T; Ejima A; Takasugi N; Mafune E; Hayashi T; Suwa K
Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):240-5. PubMed ID: 6746147
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability of griseofulvin plain tablets in stomach-emptying controlled rabbits and the correlation with bioavailability in humans.
Aoyagi N; Ogata H; Kaniwa N; Ejima A
J Pharmacobiodyn; 1984 Sep; 7(9):630-40. PubMed ID: 6527208
[TBL] [Abstract][Full Text] [Related]
10. Correlation of the bioavailability of diazepam from uncoated tablets in beagle dogs with its dissolution rate and bioavailability in humans.
Ogata H; Aoyagi N; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A; Shimamoto T; Yashiki T; Ogawa Y; Uda Y; Nishida Y
Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):576-81. PubMed ID: 6818163
[TBL] [Abstract][Full Text] [Related]
11. The bioavailability of ultramicrosize griseofulvin (Gris-PEG) tablets in man.
Barrett WE; Bianchine JR
Curr Ther Res Clin Exp; 1975 Sep; 18(3):501-9. PubMed ID: 810310
[No Abstract] [Full Text] [Related]
12. The bioavailability of griseofulvin PEG ultramicrosize (Gris-PEG) tablets in man under steady-state conditions.
Barrett WE; Hanigan JJ
Curr Ther Res Clin Exp; 1975 Sep; 18(3):491-500. PubMed ID: 810309
[No Abstract] [Full Text] [Related]
13. Use of rabbits for GI drug absorption studies: relationship between dissolution rate and bioavailability of griseofulvin tablets.
Maeda T; Takenaka H; Yamahira Y; Noguchi T
J Pharm Sci; 1979 Oct; 68(10):1286-9. PubMed ID: 512862
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal absorption of griseofulvin from corn oil-in-water emulsions: effect of amount of corn oil ingested in man.
Bates TR; Pieniaszek HJ; Sequeira JA; Rasmussen JE
Arch Dermatol; 1977 Mar; 113(3):302-6. PubMed ID: 843096
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of griseofulvin from a novel capsule formulation.
Fell JT; Calvert RT; Riley-Bentham P
J Pharm Pharmacol; 1978 Aug; 30(8):479-82. PubMed ID: 28393
[TBL] [Abstract][Full Text] [Related]
16. Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs.
Cundy KC; Sue IL; Visor GC; Marshburn J; Nakamura C; Lee WA; Shaw JP
J Pharm Sci; 1997 Dec; 86(12):1334-8. PubMed ID: 9423141
[TBL] [Abstract][Full Text] [Related]
17. Human plasma and skin blister fluid levels of griseofulvin after its repeated administration.
Schäfer-Korting M; Korting HC; Mutschler E
Eur J Clin Pharmacol; 1985; 29(3):351-4. PubMed ID: 4076331
[TBL] [Abstract][Full Text] [Related]
18. Solid crystal suspensions containing griseofulvin--preparation and bioavailability testing.
Reitz E; Vervaet C; Neubert RH; Thommes M
Eur J Pharm Biopharm; 2013 Feb; 83(2):193-202. PubMed ID: 23108185
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin.
Ahmed IS; Aboul-Einien MH
Eur J Pharm Sci; 2007 Sep; 32(1):58-68. PubMed ID: 17628451
[TBL] [Abstract][Full Text] [Related]
20. Human plasma and skin blister fluid levels of griseofulvin following a single oral dose.
Schäfer-Korting M; Korting HC; Mutschler E
Eur J Clin Pharmacol; 1985; 29(1):109-13. PubMed ID: 4054199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
